M H Veeder

1.5k total citations
13 papers, 1.1k citations indexed

About

M H Veeder is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, M H Veeder has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in M H Veeder's work include Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). M H Veeder is often cited by papers focused on Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). M H Veeder collaborates with scholars based in United States, India and Canada. M H Veeder's co-authors include Charles L. Loprinzi, Terry M. Therneau, J A Mailliard, James E. Krook, Ann Marie Dose, John Camoriano, James N. Ingle, James R. Egner, Philip J. Stella and Nancy L. Vaught and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Journal of Infectious Diseases.

In The Last Decade

M H Veeder

13 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M H Veeder United States	11	637	369	341	311	200	13	1.1k
Kathy Pan United States	16	604 0.9×	224 0.6×	320 0.9×	133 0.4×	132 0.7×	76	1.4k
Kiran Sharma India	20	305 0.5×	72 0.2×	73 0.2×	201 0.6×	139 0.7×	61	1.3k
Lucas Leite Cunha Brazil	19	389 0.6×	547 1.5×	79 0.2×	189 0.6×	122 0.6×	45	1.1k
Rachel Derr United States	12	427 0.7×	665 1.8×	144 0.4×	135 0.4×	27 0.1×	17	1.4k
Peggy Wan United States	15	377 0.6×	116 0.3×	325 1.0×	212 0.7×	153 0.8×	22	971
Mathew Vithayathil United Kingdom	18	240 0.4×	85 0.2×	247 0.7×	146 0.5×	109 0.5×	45	963
Sven Lundberg Sweden	12	247 0.4×	157 0.4×	60 0.2×	810 2.6×	84 0.4×	21	1.2k
Christine J. O’Neill Australia	19	225 0.4×	620 1.7×	282 0.8×	112 0.4×	80 0.4×	48	1.3k
Nikolaj Frost Germany	16	368 0.6×	110 0.3×	95 0.3×	400 1.3×	46 0.2×	58	1.0k
I S Fentiman United Kingdom	17	479 0.8×	82 0.2×	255 0.7×	52 0.2×	179 0.9×	37	1.0k

Countries citing papers authored by M H Veeder

Since Specialization

Citations

This map shows the geographic impact of M H Veeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M H Veeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M H Veeder more than expected).

Fields of papers citing papers by M H Veeder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M H Veeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M H Veeder. The network helps show where M H Veeder may publish in the future.

Co-authorship network of co-authors of M H Veeder

This figure shows the co-authorship network connecting the top 25 collaborators of M H Veeder. A scholar is included among the top collaborators of M H Veeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M H Veeder. M H Veeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Mehta, Minesh P., David H. Johnson, Helmut Wagner, et al.. (2003). Induction chemotherapy followed by standard thoracic radiotherapy vs. hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small cell lung cancer: phase III study of the eastern cooperative oncology group (ECOG 2597). International Journal of Radiation Oncology*Biology*Physics. 57(2). S141–S141. 8 indexed citations

Jett, James R., et al.. (2000). Phase II trial of topotecan and paclitaxel (TP) with G-CSF support alternating with etoposide and cisplatin (EC) in previously untreated extensive stage small cell lung cancer (ED-SCLC): A North Central Cancer Treatment Group study. Lung Cancer. 29(1). 52–52. 7 indexed citations

Barton, Debra L., Charles L. Loprinzi, Susan K. Quella, et al.. (1998). Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.. Journal of Clinical Oncology. 16(2). 495–500. 288 indexed citations

Veeder, M H, et al.. (1996). Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor. Journal of Neuro-Oncology. 30(3). 243–6. 10 indexed citations

Maksymiuk, Andrew W., James R. Jett, John D. Earle, et al.. (1994). Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial.. Journal of Clinical Oncology. 12(1). 70–76. 53 indexed citations

Goldberg, Richard M., Charles L. Loprinzi, Judith R. OʼFallon, et al.. (1994). Transdermal clonidine for ameliorating tamoxifen-induced hot flashes.. Journal of Clinical Oncology. 12(1). 155–158. 216 indexed citations

Creagan, Edward T., Donald I. Twito, Daniel J. Schaid, et al.. (1991). A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinoma.. Journal of Clinical Oncology. 9(12). 2104–2109. 42 indexed citations

Dose, Ann Marie, Charles L. Loprinzi, M H Veeder, et al.. (1991). Inhibition of fluorouracil-induced stomatitis by oral cryotherapy.. Journal of Clinical Oncology. 9(3). 449–452. 202 indexed citations

Jett, James R., Terry M. Therneau, Patrick S. Johnson, et al.. (1990). Bolus Versus Infusion Regimens of Etoposide and Cisplatin in Treatment of Non-Small Cell Lung Cancer: A Study of the North Central Cancer Treatment Group. JNCI Journal of the National Cancer Institute. 82(24). 1899–1903. 17 indexed citations

10.

Camoriano, John, et al.. (1990). Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer.. Journal of Clinical Oncology. 8(8). 1327–1334. 225 indexed citations

11.

Jett, James R., Lloyd K. Everson, Terry M. Therneau, et al.. (1990). Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group.. Journal of Clinical Oncology. 8(1). 33–38. 47 indexed citations

12.

Morton, Roscoe F., Edward T. Creagan, Stephen A. Cullinan, et al.. (1987). Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma.. Journal of Clinical Oncology. 5(7). 1078–1082. 22 indexed citations

13.

Veeder, M H, et al.. (1981). Recurrent Bacterial Meningitis Associated with C8 and IgA Deficiency. The Journal of Infectious Diseases. 144(5). 399–402. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact